Ameloblastoma Treatment and Reconstruction

11. Odontogenic Tumor: A Case Report of a multicystic ameloblastoma in mandible treated with intraoral bone graft surgery and osseointegrated implants By Luis Eduardo Benevides de Moraes, Eduardo Jose de Moraes, Nathalia Benevides de Moraes

The ameloblastoma is an invasive odontogenic tumor with benign character and might promote bony destruction. A large number of approaches are preconized such as aggressive resections with safety margin which lead to functional and esthetical sequelae. The present article consists in a case report of a 24 years old female patient presenting a multicystic ameloblastoma in the anterior region of the mandible. The patient was submitted to a conservative resection followed by bony reconstruction with autogenous bone graft taken from the retromolar region associated to PRP ( platelet-rich plasma). After satisfactory remodeling of the graft, osseointegrated implants were installed and the patient was rehabilitated with a fixed prosthesis. Patient was followed for a period of 5 years showing no signs of recurrence. It is possible to conclude that the treatment performed in this case provided lower morbidity and was able to satisfy patient’s expectations.

21. Improving Peri-implant Soft Tissue Profiles Using a Novel Immediate Provisionalization and Flapless Implant Placement Technique: Case Presentation By Mohamad Koutrach, Bassam M. Kinaia, Harold E. Goodis

Achieving predictable esthetic results in the anterior maxilla are a challenge for clinicians mainly due to lack of adequate soft and hard tissues volume. To predictably obtain pleasing results, early soft tissue management is necessary especially during implant temporization period.

41. Substance Abuse & Misuse of Prescription Drugs for Temporomandibular Disorders By Paul J. Flaer, Jai Parkash, Saif Algarugly, Seng Kyu Choi

Prescription drugs in the United States are often subject to abuse or misuse. Opioids are the most abused and misused analgesics of the narcotic drugs. The article deals with abuse and misuse problems associated with other groups of prescription drugs that are used in temporomandibular joint (TMJ) therapy, i.e., tranquilizers, muscle relaxants, and antidepressants. Therapy for Temporomandibular Disorder (TMD) often employs these drugs on an acute or chronic basis.